SC 13G: VEON Ltd.

AI Summary

SC 13G filing by VEON Ltd..

Risk Assessment

Risk Level: low

Key Financial Figures

• $0.001 — d. (Name of Issuer) Common shares, US$0.001 nominal value per share (Title of Clas

Filing Documents

• p24-2904sc13g.htm (SC 13G) — 58KB
• p24-2904exhibit1.htm (EX-1) — 3KB
• 0000902664-24-005703.txt ( ) — 63KB

(a)

Item 1(a). NAME OF ISSUER Veon Ltd. (the " Issuer ")

(b)

Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES Claude Debussylaan 88 1082 MD, Amsterdam The Netherlands

(a)

Item 2(a). NAME OF PERSON FILING (i) Helikon Investments Limited a United Kingdom public limited company (" Helikon UK "), with respect to the Common Shares (as defined in Item 2(d) below) and Common Shares represented by ADSs, held by Helikon Long Short Equity Fund Master ICAV (the " Helikon Fund ") managed by Helikon UK; and (ii) Federico Riggio (" Mr. Riggio ", and together with Helikon UK, the " Reporting Persons "), with respect to the Common Shares and Common Shares represented by ADSs directly held by the Helikon Fund.

(b)

Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE OR, IF NONE, RESIDENCE (i) Helikon UK; 105 Jermyn Street, London SW1Y 6EE (ii) Mr. Riggio 105 Jermyn Street, London SW1Y 6EE.

(c)

Item 2(c). CITIZENSHIP Helikon UK is a United Kingdom public limited company organized under the laws of the United Kingdom. Mr. Riggio is a citizen of the Italy.

(d)

Item 2(d). TITLE OF CLASS OF SECURITIES Common shares, US$0.001 nominal value per share (the " Common Shares ").

(e)

Item 2(e). CUSIP NUMBER There is no CUSIP number assigned to the Common Shares. CUSIP number 91822M502 has been assigned to the ADS of the Issuer, which are quoted on the NASDAQ Capital Market under the symbol "VEON." Each ADS represents 25 Common Shares. CUSIP No. 91822M502 13G Page 5 of 7 Pages Item 3. IF THIS STATEMENT IS FILED PURSUANT TO Rules 13d-1(b), OR 13d-2(b) OR (c), CHECK WHETHER THE PERSON FILING IS A: (a) ¨ Broker or dealer registered under Section 15 of the Act; (b) ¨ Bank as defined in Section 3(a)(6) of the Act; (c) ¨ Insurance company as defined in Section 3(a)(19) of the Act; (d) ¨ Investment company registered under Section 8 of the Investment Company Act of 1940; (e) ¨ An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); (f) ¨ An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); (g) x A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); (h) ¨ A savings association as defined in Section 3(b) of the Federal Deposit Insurance Act; (i) ¨ A church plan that is excluded from the definition of an investment company under Section 3(c)(14) of the Investment Company Act; (j) x A non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J); (k) ¨ Group, in accordance with Rule 13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 13d-1(b)(1)(ii)(J), please specify the type of institution: Helikon UK is an investment manager, authorized and regulated by the Financial Conduct Authority in the United Kingdom which is comparable to the regulatory scheme applicable to the investment advisers covered by Item 3(e) above. Item 4. The percentages used herein are calculated based upon 1,849,190,667 Common Shares outstanding as of June 30, 2024, as reported in the Issuer's Report of Foreign Issuer on Form 6-K filed with the Securities and Exchange Commiss

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. DATE: October 4, 2024 Helikon Investments Limited /s/ Paul McLernon Name:Paul McLernon Title:Director /s/ Federico Riggio FEDERICO RIGGIO

View Full Filing

View this SC 13G filing on SEC EDGAR